• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 62-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
112-6839058-3/1/1 20-Aug-2009 62CAA65 3005673040 TEVA UK Limited United Kingdom
 
112-6700441-7/1/1 21-Aug-2009 62CCA47 3004127709 Pfizer Limited India
 
112-6821347-0/1/2 20-Aug-2009 62CCA65 2518137 AstraZeneca Pharmaceuticals LP United States
 
BHC-5003124-2/7/1 21-Aug-2009 62CDA68 3003089536 Daiichi Sankyo Pharma Development United States
 
112-6570795-3/3/1 03-Aug-2009 62FBO17 3002512569 Metabolics Ltd United Kingdom
 
XXX-0255217-3/1/5 15-Aug-2009 62FCC13 3004007538 Lainez Laboratorios Y Drogueria El Salvador
 
AEK-9916628-8/1/1 26-Aug-2009 62GCA18 3007727935 Almco Trading Fzco United Arab Emirates
 
112-8224922-9/1/1 10-Aug-2009 62GCA86 3007681600 Glaxo Smithkline Indonesia
 
523-0861128-5/1/1 05-Aug-2009 62GCS99 3003735909 Nantong Jinghua Pharmaceutical Co., Ltd. China
 
112-5257846-6/1/1 18-Aug-2009 62GCY16 3005673557 Dermacare S.A Colombia
 
112-7336374-0/1/2 26-Aug-2009 62GDO18 3005325086 Novartis Farma Italy
 
112-7336374-0/1/3 26-Aug-2009 62GDY18 3005325086 Novartis Farma Italy
 
112-7336374-0/1/1 26-Aug-2009 62GDZ18 1000383130 Bayer S.P.A. Italy
 
112-5407258-3/1/1 18-Aug-2009 62ICZ99 3006110823 Phyton Biotech LLC Canada
 
BHC-5003124-2/11/1 21-Aug-2009 62IDA30 3003092769 Teva Pharmaceuticals USA United States
 
BHC-5003124-2/36/1 21-Aug-2009 62JDA15 1219205 Boehringer Ingelheim Pharmaceuticals, Inc. United States
 
BHC-5003124-2/26/1 21-Aug-2009 62KDA08 3007702683 American Fare United States
 
112-6698435-3/1/1 21-Aug-2009 62KIA10 3005648921 Carter Pharmaceutical Consulting Canada
 
112-6911228-3/1/1 20-Aug-2009 62KIZ10 3003941038 Shouguang Fukang Pharmaceutical Co., Ltd. China
 
112-7383944-2/2/1 26-Aug-2009 62KQL10 3007535466 David Dwyer Canada
 
112-6911569-0/1/1 20-Aug-2009 62LDB49 3005419344 Roche Products Limited United Kingdom
 
BHC-5003124-2/30/1 21-Aug-2009 62LDH40 3000718267 Barr Laboratories, Inc. (div. Of Teva) United States
 
XXX-0239752-0/1/1 25-Aug-2009 62LJK47 3002764224 Merial Saude Animal Ltda. Brazil
 
112-6878180-7/1/1 20-Aug-2009 62OCA03 3006443231 Therval Medical France
 
112-6787822-4/1/1 20-Aug-2009 62OCY03 3000248186 Servier Canada
 
112-6928019-7/1/3 21-Aug-2009 62ODA03 3004588966 Merck Frost Canada Canada
 
BHC-5003124-2/35/1 21-Aug-2009 62ODA14 3002896610 Ethex Corp United States
 
BHC-5003124-2/23/2 21-Aug-2009 62ODA34 3007702691 Ranbaxy-Generic Products United States
 
144-2774407-6/1/1 06-Aug-2009 62QPY07 3003043386 Xian High Tech Industries Co Ltd China
 
112-6469035-8/1/1 18-Aug-2009 62TCA02 3004447666 Takeda Global Research & Development United States
 
112-4739630-5/1/2 19-Aug-2009 62TCB02 3003670128 Square pharmaceuticals Ltd Bangladesh
 
112-7279577-7/1/1 26-Aug-2009 62UAP99 3007518877 Sanofi-Aventis Sa Switzerland
 
BHC-5003124-2/11/3 21-Aug-2009 62VDH18 3003092769 Teva Pharmaceuticals USA United States
 
112-6433745-5/1/1 19-Aug-2009 62VIS31 3002167290 Roche Products Ltd United Kingdom
 
UPS-5304529-8/1/1 03-Aug-2009 62WBR99 3002585284 Bowers Medical Supply Canada
 
BHC-5003124-2/4/2 21-Aug-2009 62YDA07 3006234685 Mylan Lab Inc United States
 
-
-